BioCentury
ARTICLE | Management Tracks

Biopharma is headed in the right direction on DEI. Now put the foot on the gas

Commitment to diversity, equity and inclusion is necessary but not sufficient. Balancing out the C-suite is the step change that’s needed

August 31, 2022 10:06 PM UTC

Biopharma’s initiatives on diversity, equity and inclusion have been noticed by its workforce, and on the whole are gaining a nod of approval, at least for effort. How fast the work can progress from commitment to results will hinge on companies building diversity into leadership teams.

The seeds of change are most evident at pharmas and public biotechs, who’ve understood the call from employees to do better on diversity, equity and inclusion (DEI), as well as the public’s demand for the world’s largest employers to create more equitable workplaces...